Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Other financing activities: 2009-2023

Historic Other financing activities for BIO-TECHNE (TECH) over the last 15 years, with Jun 2023 value amounting to -$2.5 million.

  • BIO-TECHNE's Other financing activities rose 89.43% to -$2.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$16.2 million, marking a year-over-year decrease of 1079.63%. This contributed to the annual value of -$2.5 million for FY2023, which is 411.80% down from last year.
  • Per BIO-TECHNE's latest filing, its Other financing activities stood at -$2.5 million for FY2023, which was down 411.80% from $788,000 recorded in FY2022.
  • In the past 5 years, BIO-TECHNE's Other financing activities registered a high of $28.1 million during FY2021, and its lowest value of -$2.5 million during FY2023.
  • Its 3-year average for Other financing activities is $8.8 million, with a median of $788,000 in 2022.
  • In the last 5 years, BIO-TECHNE's Other financing activities soared by 280.68% in 2019 and then tumbled by 411.80% in 2023.
  • Yearly analysis of 5 years shows BIO-TECHNE's Other financing activities stood at $7.2 million in 2019, then soared by 145.83% to $17.7 million in 2020, then spiked by 58.76% to $28.1 million in 2021, then slumped by 97.20% to $788,000 in 2022, then tumbled by 411.80% to -$2.5 million in 2023.